Regeneron Pharmaceuticals, Inc. nears a key earnings report after a strong JPM Healthcare update. Click here to find out why ...

A new University of Manchester and Edinburgh study published in the journal Brain, Behavior and Immunity has found that ...

Subclade K (previously known as J.2.4.1) is gaining attention because it appears to be spreading much earlier in the flu ...

Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...

Parents of autistic children are clamoring for a prescription vitamin promoted by federal health officials. But there's ...

Parents of autistic children are clamoring for a prescription vitamin promoted by federal health officials. But there's ...

Let’s say it’s 2036, and scientists are working on a new class of drugs. Today, for instance, pharmaceutical companies use ...

This biotech small-cap's grown its dividend by 140% since 2016! So with an 8.3% yield, is now the time to add it to my Stocks ...

Whether in popcorn, chips or a new beverage, protein-containing snacks have become popular. With this rise in protein-filled ...

The panel discussion, “Innovations in Breast Cancer Treatment,” examined the challenge of maintaining or increasing access to care as breast cancer treatment becomes more stratified through biomarker ...

More must be done to ensure that asthma patients get access to cutting-edge treatments, experts have said, after research found that 66% of eligible patients are not receiving gold standard care.

For a long time, treatments for autoimmune diseases could only quash the symptoms - now new drugs may tackle the underlying ...